Handelsbanken Fonder AB Trims Stake in Agilent Technologies, Inc. $A

Handelsbanken Fonder AB trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 4.4% in the 4th quarter, Holdings Channel reports. The firm owned 143,413 shares of the medical research company’s stock after selling 6,529 shares during the quarter. Handelsbanken Fonder AB’s holdings in Agilent Technologies were worth $19,514,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Board of the Pension Protection Fund bought a new stake in shares of Agilent Technologies during the fourth quarter worth $27,000. Navalign LLC purchased a new position in shares of Agilent Technologies during the fourth quarter worth approximately $27,000. Physician Wealth Advisors Inc. increased its position in shares of Agilent Technologies by 490.0% during the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after acquiring an additional 196 shares during the period. Entrust Financial LLC purchased a new position in shares of Agilent Technologies during the fourth quarter worth approximately $31,000. Finally, Torren Management LLC purchased a new position in shares of Agilent Technologies during the fourth quarter valued at $32,000.

Agilent Technologies Price Performance

Shares of A opened at $113.64 on Thursday. The firm has a market capitalization of $32.11 billion, a PE ratio of 25.09, a price-to-earnings-growth ratio of 2.33 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. Agilent Technologies, Inc. has a 1-year low of $107.07 and a 1-year high of $160.27. The company’s fifty day moving average price is $114.79 and its 200-day moving average price is $129.89.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period last year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities research analysts predict that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Analyst Ratings Changes

A has been the topic of several research reports. TD Cowen cut their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Barclays cut their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. UBS Group cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Wells Fargo & Company cut their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Finally, Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $163.71.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.